Standardised definition of resectability for N2 non-small cell lung cancer and selection criteria for sequence of treatment allocation. Variability between guidelines, including Q&A - Amsterdam 2025

Clinical challenges beyond guidelines

Chair(s): Torsten Gerriet Blum, Dragos Bumbacea, Daiana Stolz

Session type: Clinical cases

Standardised definition of resectability for N2 non-small cell lung cancer and selection criteria for sequence of treatment allocation. Variability between guidelines, including Q&A

Alessandro Brunelli

EVENTS HOME

Replay
Slides

Previous presentation

Next presentation

Session content

Limitations of acute respiratory distress syndrome guidelines, including Q&A

Ana Cysneiros

Replay

Slides

Weak points of modern guidelines for malignant pleural mesothelioma and future perspectives, including Q&A

Nuria M. Novoa

Replay

Slides

Overcoming barriers to access and implementing tuberculosis short regimens, including Q&A

Lorenzo Guglielmetti

Replay

Slides

Standardised definition of resectability for N2 non-small cell lung cancer and selection criteria for sequence of treatment allocation. Variability between guidelines, including Q&A

Alessandro Brunelli

Replay

Slides

Session aims

to describe the controversial aspects of the current guidelines for acute respiratory distress syndrome, mesothelioma, tuberculosis short regimens and resectability for N2 non-small cell lung cancer and selection criteria for the sequence of treatment allocation; to propose evidence-based substitute management recommendations for clinicians; to identify areas of concern; to highlight the need for further research; to explain the limitations of the guidelines in order to put them in perspective and clinical practice.

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}